Ratings National Health Investors, Inc.

Equities

NHI

US63633D1046

Market Closed - Nyse 04:00:02 2024-05-31 pm EDT 5-day change 1st Jan Change
66.08 USD +1.30% Intraday chart for National Health Investors, Inc. +1.71% +18.32%

Strengths

  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • The company is one of the best yield companies with high dividend expectations.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
  • Analyst opinion has improved significantly over the past four months.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

  • The company's earnings growth outlook lacks momentum and is a weakness.
  • One of the major weak points of the company is its financial situation.
  • The firm trades with high earnings multiples: 22.98 times its 2024 earnings per share.
  • Based on current prices, the company has particularly high valuation levels.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialized REITs

1st Jan change Capi. Investor Rating ESG Refinitiv
+18.32% 2.87B
C-
+14.97% 61.99B
A-
+0.84% 20.31B
A-
+0.51% 14.01B
A
+5.45% 7.99B
B
-5.80% 6.14B
B-
+14.32% 3.63B
C-
+2.24% 3.38B
C+
+9.16% 3.22B
C
-6.13% 3.08B
B+
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. NHI Stock
  4. Ratings National Health Investors, Inc.